EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

 ISSN 2394-3211

Impact Factor: 7.065

 ICV - 79.57

Abstract

EVALUATION OF IN VITRO AND IN VIVO ANTICANCER ACTIVITY OF THE EXTRACTS OF KEDROSTIS ROSTRATA

T.S. Arun*, Rakesh Kumar Jat and J. Jaslin Edward

ABSTRACT

The present study was designed with the object of exploring the anticancer property of the extracts of aerial parts of Kedrostis rostrata by in vitro and in vivo methods. Initially, the petroleum ether, chloroform, ethyl acetate and methanol extracts were screened in vitro by MTT assay using MCF7 and SKMEL cell lines. The methanol extract showed a significant activity in the in vitro evaluation. Based on the results of in vitro evaluation, the methanol extract was selected for the in vivo evaluation on Swiss albino mice with tumour induced by Ehrlich ascites carcinoma cells. Standard drug 5-fluorouracil (20mg.kg-1) was used for the comparative evaluation. Initially, the methanol extract was subjected to toxicity evaluation. The results showed that the ED50 of the extract was 200mg.kg-1. In the in vivo evaluation, two doses of extracts, 200 and 400mg.kg-1 were subjected to screening. Various aspects viz., clinical, hematological and biochemical parameters of the experimental animals were analyzed in the in vivo evaluation. The results showed that the animals treated with the methanol extract showed significant reduction in body weight comparing with tumor control animals. In case of average life span, the tumor control animals showed the life span of 47% whereas, animals treated with the methanol extract at the dose of 200 and 400mg.kg-1 showed the life span of 73% and 78% respectively. The reduction in the viable tumor cell count and changes in hematological and biochemical parameters also support the antitumor nature of the methanol extract of K. rostrata. From these studies, it is clear that further works needed to be done in the future for the development of clinically useful chemotherapeutic agents.

Keywords: Kedrostis rostrata extracts, MTT assay, Swiss albino mice, Ehrlich ascites carcinoma cells.


[Full Text Article] [Download Certificate]

Citation

  All Since 2019
 Citation  3086  2560
 h-index  18  17
 i10-index  64  44

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 July 2024 Issue has been Published, Kindly check it on https://www.ejpmr.com/issue

  • EJPMR: JULY ISSUE PUBLISHED

    JULY 2024 issue has been successfully launched on JULY 2024.

  • EJPMR New Impact Factor

    EJPMR Impact Factor has been Increased to 7.065 for Year 2024.

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI ) Scope Database Academia